Pasithea Therapeutics Corp.

NasdaqCM: KTTA · Healthcare

Positivity Index

#2,932 / 6,774

Global

#1,106 / 4,000

United States

Positivity Score

21,014

Rank→

PosiRed: 2 active red flags (highest severity 6/10) View flag history →

PosiRed · red flag

Stock exchange listing-rule deficiency notice (8-K Item 3.01)

The company reported in a Form 8-K (Item 3.01) filed on 21 Aug 2026 that its stock exchange notified it of not meeting a continued-listing rule. Continued non-compliance can lead to delisting.

More details →

PosiRed · red flag

Stock exchange listing-rule deficiency notice (8-K Item 3.01)

The company reported in a Form 8-K (Item 3.01) filed on 20 Feb 2026 that its stock exchange notified it of not meeting a continued-listing rule. Continued non-compliance can lead to delisting.

More details →

Pasithea Therapeutics Corp. — Overview & Financial Snapshot

Pasithea Therapeutics Corp. (NasdaqCM: KTTA) is a Healthcare company, ranked #2,932 of 6,774 companies globally and #1,106 of 4,000 in United States on PositoAI, with a Positivity Score of 21,014. Its market capitalisation is ₹140.42 Cr ($14.88M), P/E ratio is -0.3 and P/B ratio is 0.30. It currently has 2 active red flags (PosiRed) and no yellow flags (PosiYellow) on record.

For financial statements, ratio trends and score history, Go Deep →

What does Pasithea Therapeutics Corp. do?

Pasithea Therapeutics Corp., a clinical-stage biotechnology company, focuses on the discovery, research, and development of treatments for central nervous system (CNS) disorders, RASopathies, and cancers. Its lead product candidate is PAS-004, a next-generation macrocyclic mitogen-activated protein kinase, or MEK…

What is Pasithea Therapeutics Corp.'s P/E and P/B ratio?

Pasithea Therapeutics Corp. has a P/E ratio of -0.3 and a P/B ratio of 0.30.

What is Pasithea Therapeutics Corp.'s debt-to-equity ratio?

Pasithea Therapeutics Corp. has a debt-to-equity ratio of 0.00.

How much does Pasithea Therapeutics Corp. owe compared with what it owns?

Pasithea Therapeutics Corp. owes $0.04 for every $1 it owns (balance sheet Jun 2026), which is low.

What is Pasithea Therapeutics Corp.'s Positivity rank?

Pasithea Therapeutics Corp. is ranked #2,932 of 6,774 companies globally and #1,106 of 4,000 in United States on PositoAI, with a Positivity Score of 21,014.

Does Pasithea Therapeutics Corp. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?

Yes. Pasithea Therapeutics Corp. has 2 active red flags (PosiRed) on record: Stock exchange listing-rule deficiency notice (8-K Item 3.01) (dated 21 Aug 2026); Stock exchange listing-rule deficiency notice (8-K Item 3.01) (dated 20 Feb 2026). It has no yellow flags.

Where can I read the latest news about Pasithea Therapeutics Corp.?

Recent headlines about Pasithea Therapeutics Corp. from the last 30 days, with links to the original articles, are on its News page on PositoAI.

Does Pasithea Therapeutics Corp. have a PositoAI PosiShot or QR code?

Yes. A dated PosiShot of Pasithea Therapeutics Corp.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.